Corrigendum to “Evaluation of commercial quadrivalent foot-and-mouth disease vaccines against east African virus strains reveals limited immunogenicity and duration of protection” [Vaccine 42 (1–12) (2024) 126325]
Back to publicationsPublication
Contributors
Kerfua SD, Haydon DT, Wilsden G, Ludi A, King DP, Okurut RA, AtimS, Dhikusooka MT, Kyakuwa I, Motta P, Paton DJ
Year
2024
Journal
Vaccine